Genomma Approaches Domestic Bond Debut
Genomma Lab is targeting Thursday for the sale of up to MXP2.0bn ($157m) in what would be the Mexican pharmaceutical and...
Already have an account?
Subscribe now for unlimited access to all current and archive news, data and market analysis.
Take a free two-week trial now for the latest news, data and market analysis.